---
title: "SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 43.36 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252841541.md"
datetime: "2025-08-13T11:03:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252841541.md)
  - [en](https://longbridge.com/en/news/252841541.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252841541.md)
generator: "portal-rs"
---

# SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 43.36 M

Revenue: As of FY2025 Q2, the actual value is USD 43.36 M.

EPS: As of FY2025 Q2, the actual value is USD 0.02.

EBIT: As of FY2025 Q2, the actual value is USD 15.19 M.

### Segment Revenue

-   Total revenues for the second quarter of 2025 were $43 million, an 18% decrease year-over-year.
-   Total revenues for the first half of 2025 were $91 million, a 16% decrease year-over-year.

### Operational Metrics

-   Income from operations for the second quarter was $15 million, a 47% decrease year-over-year.
-   Net income attributable to SBC Medical Group for the second quarter was $2.5 million, an 87% decrease year-over-year.
-   EBITDA for the second quarter was $15 million, a 46% decrease year-over-year, with an EBITDA margin of 35% compared to 53% in the second quarter of 2024.
-   Income from operations for the first half was $39 million, a 25% decrease year-over-year.
-   Net income attributable to SBC Medical Group for the first half was $24 million, a 36% decrease year-over-year.
-   EBITDA for the first half was $40 million, a 25% decrease year-over-year, with an EBITDA margin of 44% compared to 50% in the first half of 2024.

### Cash Flow

-   Net cash used in operating activities for the first half of 2025 was - $6,411,168, compared to $22,874,760 provided in the same period of 2024.
-   Net cash provided by investing activities for the first half of 2025 was $15,397,998, compared to - $9,405,716 used in the same period of 2024.
-   Net cash provided by financing activities for the first half of 2025 was $6,901,719, compared to - $109,341 used in the same period of 2024.

### Unique Metrics

-   The number of franchise locations increased to 259 as of June 30, 2025, up by 36 locations from June 30, 2024.
-   The number of customers in the last twelve months ended June 30, 2025, was 6.31 million, a 14% increase year-over-year.
-   The repeat rate for customers who visited franchisee’s clinics twice or more was 72%.

### Outlook / Guidance

-   SBC Medical is executing strategic shifts aimed at long-term competitiveness and scalability, including the discontinuation of the staffing business and targeted divestitures.
-   The company is focused on optimizing its franchise model, capturing growth opportunities, transitioning to higher-margin models, and delivering lasting value to shareholders.
-   Despite challenges in Japan’s consumer discretionary market, SBC Medical is advancing key initiatives, including the acquisition of MB career lounge and the integration of JUN CLINIC into its network.

### Related Stocks

- [SBCWW.US](https://longbridge.com/en/quote/SBCWW.US.md)

## Related News & Research

- [Southern Copper (NYSE:SCCO) Shares Up 8.3%  - Still a Buy?](https://longbridge.com/en/news/296638179.md)
- [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md)
- [Andrew Polovin Sells 22,148 Shares of Tempus AI (NASDAQ:TEM) Stock](https://longbridge.com/en/news/296610788.md)
- [MSH Capital Advisors LLC Acquires New Shares in Chevron Corporation $CVX](https://longbridge.com/en/news/296598647.md)
- [Pioneer Wealth Management Group Purchases 6,640 Shares of Apple Inc. $AAPL](https://longbridge.com/en/news/296591265.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**